‘Plastic antibodies’ developed halts spread of deadly bee venom in mice.
In a breakthrough study, researchers at UC Irvine have developed the first “plastic antibodies” and successfully introduced them into the blood of mice to halt the spread of deadly bee venom.
Continue reading… “Scientists Create ‘Plastic Antibodies’ to Fight Antigens”
Every year, millions of people are diagnosed with cancer – a remarkably high number. But what about the flipside of those statistics? That is, two out of three people never get cancer, and more than half of heavy smokers don’t get cancer, either. A recent study points out this overlooked fact, and suggests that researchers might discover something by asking why so many people are resistant to the often deadly disease.
Continue reading… “Why Are A Majority Of People Resistant To Cancer?”
A new system for detecting cancer proteins uses the same magnetic phenomenon that lets computer hard drives read and write data. The Stanford University researchers developing the system hope that it will detect cancer in its earlier stages, when it’s easier to treat. MagArray, a startup in Sunnyvale, CA, will commercialize the technology.
Continue reading… “A New Way To Detect Cancer Early”
Beacon Biotechnology has created a disruptive medical device technology with a single use, disposable, rapid, 112 test microarray diagnostic testing platform capable of performing both molecular and immunoassay methods.
Continue reading… “Beacon Biotechnology – Diagnostic Medical Device Technology”
Stem cells from human testes could be used for personalized medicine. Adult stem cells that behave much like embryonic ones have been isolated from human testes, raising hopes for a new source of versatile stem cells without genetic manipulation or the destruction of embryos. If the new stem cells can be used therapeutically, a simple testicular biopsy could provide the starting material for personalized regenerative medicine.
Continue reading… “A Source Of Stem Cells From Men”
GlaxoSmithKline Plc’s head of biotech research is excited about a new generation of “slimline” antibody medicines that may be successors to current blockbusters such as Avastin and Rituxan.
Continue reading… “Slim Antibody Pills Are the Next Big Thing?”
